These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16925506)

  • 1. Sildenafil for pulmonary arterial hypertension: when blue turns into white.
    Antoniu SA
    Expert Opin Pharmacother; 2006 Sep; 7(13):1801-10. PubMed ID: 16925506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
    Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.
    Leibovitch L; Matok I; Paret G
    Drugs; 2007; 67(1):57-73. PubMed ID: 17209664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil: a review of its use in pulmonary arterial hypertension.
    Croom KF; Curran MP
    Drugs; 2008; 68(3):383-97. PubMed ID: 18257613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of sildenafil in pulmonary artery hypertension.
    Singh TP
    Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil for the treatment of pulmonary hypertension in pediatric patients.
    Huddleston AJ; Knoderer CA; Morris JL; Ebenroth ES
    Pediatr Cardiol; 2009 Oct; 30(7):871-82. PubMed ID: 19705181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil in the treatment of pulmonary hypertension.
    Barnett CF; Machado RF
    Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension.
    Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P
    J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil for pulmonary hypertension: need for evidence generation.
    Shafiq N; Reddy S; Pandhi P; Manoj R; Talwar KK; Malhotra S
    Int J Clin Pharmacol Ther; 2008 Dec; 46(12):644-51. PubMed ID: 19049698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not.
    Mietens A; Tasch S; Feuerstacke C; Eichner G; Volkmann J; Schermuly RT; Grimminger F; Müller D; Middendorff R
    Mol Cell Endocrinol; 2012 Feb; 349(2):145-53. PubMed ID: 21996373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights in the treatment strategy for pulmonary arterial hypertension.
    Sahara M; Takahashi T; Imai Y; Nakajima T; Yao A; Morita T; Hirata Y; Nagai R
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):377-86. PubMed ID: 17124557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil for the treatment of pulmonary hypertension in children.
    Beghetti M; Wacker Bou Puigdefabregas J; Merali S
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1157-84. PubMed ID: 25223406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.
    Ramani GV; Park MH
    Drug Des Devel Ther; 2010 May; 4():61-70. PubMed ID: 20531962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension.
    Pinto LM; Morekar S; Mahashur AA
    Indian J Chest Dis Allied Sci; 2009; 51(4):249-51. PubMed ID: 20073379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil for pulmonary hypertension complicating bronchopulmonary dysplasia.
    Bhatt-Mehta V; Donn SM
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):393-5. PubMed ID: 24866752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.
    Michelakis E; Tymchak W; Lien D; Webster L; Hashimoto K; Archer S
    Circulation; 2002 May; 105(20):2398-403. PubMed ID: 12021227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia.
    Wardle AJ; Wardle R; Luyt K; Tulloh R
    Arch Dis Child; 2013 Aug; 98(8):613-7. PubMed ID: 23625986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current pharmacological treatment of pulmonary arterial hypertension.
    Steiropoulos P; Trakada G; Bouros D
    Curr Clin Pharmacol; 2008 Jan; 3(1):11-9. PubMed ID: 18690874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
    Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.